221 related articles for article (PubMed ID: 37435078)
21. Infant Whole-Cell Versus Acellular Pertussis Vaccination in 1997 to 1999 and Risk of Childhood Hospitalization for Food-Induced Anaphylaxis: Linked Administrative Databases Cohort Study.
Pérez Chacón G; Fathima P; Jones M; Estcourt MJ; Gidding HF; Moore HC; Richmond PC; Snelling T
J Allergy Clin Immunol Pract; 2024 Mar; 12(3):670-680. PubMed ID: 38182097
[TBL] [Abstract][Full Text] [Related]
22. Antibody Specificity Following a Recent
Raeven RHM; van der Maas L; Pennings JLA; Fuursted K; Jørgensen CS; van Riet E; Metz B; Kersten GFA; Dalby T
Front Immunol; 2019; 10():1364. PubMed ID: 31275314
[No Abstract] [Full Text] [Related]
23. Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthood.
Bancroft T; Dillon MB; da Silva Antunes R; Paul S; Peters B; Crotty S; Lindestam Arlehamn CS; Sette A
Cell Immunol; 2016; 304-305():35-43. PubMed ID: 27212461
[TBL] [Abstract][Full Text] [Related]
24. Duration of protection against Bordetella pertussis infection elicited by whole-cell and acellular vaccine priming in Polish children and adolescents.
Paradowska-Stankiewicz I; Rumik A; Bogusz J; Zbrzeźniak J; Rastawicki W; Śmietańska K; Vargas-Zambrano JC; Macina D
Vaccine; 2021 Oct; 39(41):6067-6073. PubMed ID: 34511302
[TBL] [Abstract][Full Text] [Related]
25. A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against
Zurita ME; Wilk MM; Carriquiriborde F; Bartel E; Moreno G; Misiak A; Mills KHG; Hozbor D
Front Cell Infect Microbiol; 2019; 9():125. PubMed ID: 31106160
[TBL] [Abstract][Full Text] [Related]
26. Robust Humoral and Cellular Immune Responses to Pertussis in Adults After a First Acellular Booster Vaccination.
van der Lee S; van Rooijen DM; de Zeeuw-Brouwer ML; Bogaard MJM; van Gageldonk PGM; Marinovic AB; Sanders EAM; Berbers GAM; Buisman AM
Front Immunol; 2018; 9():681. PubMed ID: 29670634
[TBL] [Abstract][Full Text] [Related]
27. Pertussis Maternal Immunization: Narrowing the Knowledge Gaps on the Duration of Transferred Protective Immunity and on Vaccination Frequency.
Gaillard ME; Bottero D; Zurita ME; Carriquiriborde F; Martin Aispuro P; Bartel E; Sabater-Martínez D; Bravo MS; Castuma C; Hozbor DF
Front Immunol; 2017; 8():1099. PubMed ID: 28932228
[TBL] [Abstract][Full Text] [Related]
28. Immunological Distinctions between Acellular and Whole-Cell Pertussis Immunizations of Baboons Persist for at Least One Year after Acellular Vaccine Boosting.
Cole LE; Zhang J; Pacheco KM; Lhéritier P; Anosova NG; Piolat J; Zheng L; Reveneau N
Vaccines (Basel); 2020 Dec; 8(4):. PubMed ID: 33276673
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth: A Randomized Clinical Trial.
Wood N; Nolan T; Marshall H; Richmond P; Gibbs E; Perrett K; McIntyre P
JAMA Pediatr; 2018 Nov; 172(11):1045-1052. PubMed ID: 30208475
[TBL] [Abstract][Full Text] [Related]
30. Maternal acellular pertussis vaccination in mice impairs cellular immunity to Bordetella pertussis infection in offspring.
Dubois V; Chatagnon J; Depessemier M; Locht C
JCI Insight; 2023 Sep; 8(18):. PubMed ID: 37581930
[TBL] [Abstract][Full Text] [Related]
31. Maternal and neonatal vaccination protects newborn baboons from pertussis infection.
Warfel JM; Papin JF; Wolf RF; Zimmerman LI; Merkel TJ
J Infect Dis; 2014 Aug; 210(4):604-10. PubMed ID: 24526741
[TBL] [Abstract][Full Text] [Related]
32. Maternal Vaccination With a Monocomponent Pertussis Toxoid Vaccine Is Sufficient to Protect Infants in a Baboon Model of Whooping Cough.
Kapil P; Papin JF; Wolf RF; Zimmerman LI; Wagner LD; Merkel TJ
J Infect Dis; 2018 Mar; 217(8):1231-1236. PubMed ID: 29346585
[TBL] [Abstract][Full Text] [Related]
33. Effect of maternal immunization against pertussis in Medellin and the metropolitan area, Colombia, 2016-2017.
Hincapié-Palacio D; Hoyos MC; Ochoa J; Montoya N; García D; Osorio E;
Vaccine; 2018 Jun; 36(27):3984-3991. PubMed ID: 29789240
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence of Bordetella pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) in pregnant Thai women.
Sompagdee N; Anuwutnavin S; Phongsamart W; Senawong S; Umrod P; Robkhonburi A
Vaccine; 2020 Mar; 38(12):2725-2733. PubMed ID: 32070680
[TBL] [Abstract][Full Text] [Related]
35. Impact of Maternal Pertussis Antibodies on the Infants' Cellular Immune Responses.
Orije MRP; García-Fogeda I; Van Dyck W; Corbière V; Mascart F; Mahieu L; Hens N; Van Damme P; Cools N; Ogunjimi B; Maertens K; Leuridan E
Clin Infect Dis; 2022 Aug; 75(3):442-452. PubMed ID: 34849638
[TBL] [Abstract][Full Text] [Related]
36. Lack of evidence supporting a role of IFN-β and TGF-β in differential polarization of Bordetella pertussis specific-T cell responses.
da Silva Antunes R; Quiambao LG; Soldevila F; Sutherland A; Peters B; Sette A
Cytokine; 2021 Jan; 137():155313. PubMed ID: 33002739
[TBL] [Abstract][Full Text] [Related]
37. Antibody responses to Bordetella pertussis and other childhood vaccines in infants born to mothers who received pertussis vaccine in pregnancy - a prospective, observational cohort study from the United Kingdom.
Rice TF; Diavatopoulos DA; Smits GP; van Gageldonk PGM; Berbers GAM; van der Klis FR; Vamvakas G; Donaldson B; Bouqueau M; Holder B; Kampmann B
Clin Exp Immunol; 2019 Jul; 197(1):1-10. PubMed ID: 30758857
[TBL] [Abstract][Full Text] [Related]
38. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
[TBL] [Abstract][Full Text] [Related]
39. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
[TBL] [Abstract][Full Text] [Related]
40. Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial.
Barug D; Pronk I; van Houten MA; Versteegh FGA; Knol MJ; van de Kassteele J; Berbers GAM; Sanders EAM; Rots NY
Lancet Infect Dis; 2019 Apr; 19(4):392-401. PubMed ID: 30938299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
